Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.15 is in line with its 5-year average of 3.39, near the low end of its 5-year range (2.23–5.35).
As of the fiscal period ended Tuesday, June 30, 2026. 15.77% below its 12-month average of 3.74.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.15.
QUICK RATIO (ACID-TEST)
3.15
QUICK RATIO (ACID-TEST) AVG TTM
3.74
QUICK RATIO (ACID-TEST) AVG 3Y
3.97
QUICK RATIO (ACID-TEST) AVG 5Y
3.39
QUICK RATIO (ACID-TEST) AVG 10Y
6.34
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-15.77%
CURRENT VS 3Y AVG
-20.71%
CURRENT VS 5Y AVG
-7.19%
CURRENT VS 10Y AVG
-50.38%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-6.07%
vs the sector median at left
Ardelyx, Inc.
Market Cap
$809.02M
Quick Ratio (Acid-Test)
3.15
TTM Avg
3.74
3Y Avg
3.97
5Y Avg
3.39
Market Cap
$804.75M
Quick Ratio (Acid-Test)
14.93
TTM Avg
20.63
3Y Avg
16.30
5Y Avg
22.70
Market Cap
$792.69M
Quick Ratio (Acid-Test)
3.86
TTM Avg
4.02
3Y Avg
3.56
5Y Avg
3.80
Market Cap
$785.48M
Quick Ratio (Acid-Test)
0.98
TTM Avg
0.95
3Y Avg
0.97
5Y Avg
0.95
Market Cap
$836.41M
Quick Ratio (Acid-Test)
9.52
TTM Avg
4.26
3Y Avg
6.09
5Y Avg
7.80
Market Cap
$841.08M
Quick Ratio (Acid-Test)
7.96
TTM Avg
6.81
3Y Avg
6.62
5Y Avg
6.62
Market Cap
$782.66M
Quick Ratio (Acid-Test)
5.16
TTM Avg
4.89
3Y Avg
3.82
5Y Avg
4.31
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ardelyx, Inc. (ARDX) | $809.02M | 3.15 | 3.74 | 3.97 | 3.39 |
| Jade Biosciences, Inc. (JBIO)vs › | $804.75M | 14.93 | 20.63 | 16.30 | 22.70 |
| InMode Ltd. (INMD)vs › | $802.72M | 7.28 | 9.00 | 9.42 | 9.03 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $792.69M | 3.86 | 4.02 | 3.56 | 3.80 |
| AdaptHealth Corp. (AHCO)vs › | $785.48M | 0.98 | 0.95 | 0.97 | 0.95 |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $836.41M | 9.52 | 4.26 | 6.09 | 7.80 |
| Alumis Inc. (ALMS)vs › | $837.93M | 6.74 | 5.17 | 5.15 | 5.15 |
| Beta Bionics, Inc. (BBNX)vs › | $841.08M | 7.96 | 6.81 | 6.62 | 6.62 |
| Geron Corporation (GERN)vs › | $782.66M | 5.16 | 4.89 | 3.82 | 4.31 |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $839.01M | 25.06 | 12.67 | 12.67 | 12.67 |
Quick Ratio
3.15
Excludes inventory
Current Ratio
3.34
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.15 |
| 2026-03-31 | 3.28 |
| 2025-12-31 | 4.11 |
| 2025-09-30 | 4.11 |
| 2025-06-30 | 4.03 |
| 2025-03-31 | 3.81 |
| 2024-12-31 | 4.31 |
| 2024-09-30 | 3.87 |
| 2024-06-30 | 3.99 |
| 2024-03-31 | 4.36 |
| 2023-12-31 | 4.64 |
| 2023-09-30 | 5.35 |
| 2023-06-30 | 2.50 |
| 2023-03-31 | 2.57 |
| 2022-12-31 | 2.29 |
| 2022-09-30 | 2.28 |
| 2022-06-30 | 2.25 |
| 2022-03-31 | 2.31 |
| 2021-12-31 | 2.53 |
| 2021-09-30 | 2.23 |
| 2021-06-30 | 3.23 |
| 2021-03-31 | 4.91 |
| 2020-12-31 | 6.87 |
| 2020-09-30 | 11.72 |
| 2020-06-30 | 6.29 |
| 2020-03-31 | 9.76 |
| 2019-12-31 | 11.36 |
| 2019-09-30 | 6.27 |
| 2019-06-30 | 7.79 |
| 2019-03-31 | 7.41 |
| 2018-12-31 | 10.02 |
| 2018-09-30 | 12.82 |
| 2018-06-30 | 14.20 |
| 2018-03-31 | 10.28 |
| 2017-12-31 | 8.39 |
| 2017-09-30 | 8.50 |
| 2017-06-30 | 8.37 |
| 2017-03-31 | 9.22 |
| 2016-12-31 | 10.62 |
| 2016-09-30 | 13.28 |
| 2016-06-30 | 10.70 |
| 2016-03-31 | 14.10 |
| 2015-12-31 | 14.53 |
| 2015-09-30 | 10.61 |
| 2015-06-30 | 25.95 |
| 2015-03-31 | 5.12 |
| 2014-12-31 | 20.03 |
| 2014-09-30 | 6.00 |
| 2014-06-30 | 4.47 |
| 2014-03-31 | 2.08 |
| 2013-12-31 | 2.44 |
| 2013-09-30 | 0.00 |
| 2013-06-30 | 0.00 |
| 2013-03-31 | 0.00 |
